Last $146.06 USD
Change Today +3.06 / 2.14%
Volume 2.0M
VRX On Other Exchanges
Symbol
Exchange
Toronto
Frankfurt
As of 8:04 PM 12/19/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

J. Michael Pearson

Chairman and Chief Executive Officer, Valeant Pharmaceuticals International, Inc.
AgeTotal Calculated CompensationThis person is connected to 30 board members in 6 different organizations across 6 different industries.

See Board Relationships
55$6,997,734
As of Fiscal Year 2013

Background*

Mr. J. Michael Pearson, also known as Mike, has been the Chief Executive Officer and President at Solta Medical, Inc. since January 2014. Mr. Pearson has been the Chief Executive Officer and President of Obagi Medical Products, Inc. since April 25, 2013. He has been the Chief Executive Officer of Valeant Pharmaceuticals International, Inc. since September 2010. He joined Valeant in February 2008 as Chairman and Chief Executive Officer. He served as Chairman and Chief ...

Read Full Background

Corporate Headquarters*

2150 St. Elzéar boulevard West
Laval, Quebec H7L 4A8

Canada

Phone: 514-744-6792
Fax: 514-744-6272

Board Members Memberships*

Director and Head of Global Pharmaceutical Practice and Head of Mid-Atlantic Region
2008-N/A
Former Chairman and Chief Executive Officer
2010-Present
Chairman and Chief Executive Officer
2013-Present
Chief Executive Officer, President and Director
2014-Present
Chief Executive Officer, President and Director

Education*

BS
Duke University
BSE
Duke University
MBA
University of Virginia

Other Affiliations*

Annual Compensation*

Salary$1,750,000
Total Annual Compensation$1,750,000

Stock Options*

All Other Compensation$458,203
Exercisable Options3,956,191
Exercisable Options Value$428,898,277
Unexercisable Options976,937
Unexercisable Options Value$91,646,725
Total Value of Options$520,545,002
Total Number of Options4,933,128

Total Compensation*

Total Annual Cash Compensation$6,997,734
Total Short Term Compensation$1,750,000
Other Long Term Compensation$458,203
Total Calculated Compensation$6,997,734
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VRX:US $146.06 USD +3.06

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Heather Bresch Chief Executive Officer, Director and Member of Science & Technology Committee
Mylan, Inc.
$1.1M
Joseph C. Papa Chairman, Chief Executive Officer and President
Perrigo Company Public Limited Company
$1.1M
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$2.7M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
--
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VALEANT PHARMACEUTICALS INTE, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.